Drug comparisons
Atogepant vs Lasmiditan
Atogepant vs Lasmiditan: antimigraine agents compared by mechanism, indications, black-box warnings, and patient suitability for migraine use.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting antimigraine agents with distinct mechanisms for prevention versus acute treatment of migraine.
Bottom line
Neither is universally better; Atogepant suits CGRP antagonism for prevention without black-box warning while Lasmiditan addresses 5-HT1F agonism for acute attacks.
All medication comparisons